Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.54 USD | +6.04% |
|
+12.37% | +41.19% |
02:34pm | Evercore ISI Starts Spyre Therapeutics With Outperform Rating | MT |
07-01 | Spyre Therapeutics, Inc.(NasdaqGS:SYRE) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.19% | 1.46B | |
+20.29% | 127B | |
+24.25% | 117B | |
+25.44% | 27.67B | |
-18.52% | 20.33B | |
-15.17% | 16.79B | |
-15.91% | 15.63B | |
+12.76% | 14.84B | |
-47.10% | 14.65B | |
+57.16% | 14.43B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Evercore ISI Starts Spyre Therapeutics With Outperform Rating